| Natco Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524816 |
NSE Symbol : NATCOPHARM |
P/E(TTM) : 10.68 |
|
ISIN Demat : INE987B01026 |
Div & Yield% : 0.66 |
EPS(TTM) : 84.75 |
|
Book Value(₹) : 461.80 |
Market Cap(₹Cr) : 16,211.23 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,094.50 | 3,568.90 | 2,351.00 | 1,767.80 | 1,653.50 |
| Other Income | 321.30 | 104.70 | 85.50 | 94.60 | 101.10 |
| Stock Adjustments | -11.60 | -17.20 | -34.60 | 5.50 | 46.90 |
| Total Income | 4,404.20 | 3,656.40 | 2,401.90 | 1,867.90 | 1,801.50 |
| EXPENDITURE : | |||||
| Raw Materials | 581.70 | 557.30 | 495.10 | 540.10 | 546.90 |
| Power and Fuel Cost | 93.10 | 88.90 | 81.90 | 76.40 | 59.40 |
| Other Manufacturing Expenses | 217.70 | 179.80 | 150.30 | 148.70 | 114.30 |
| Selling and Administration Expenses | 444.10 | 483.70 | 290.70 | 309.10 | 140.30 |
| Miscellaneous Expenses | 86.70 | 150.10 | 28.00 | 75.90 | 41.90 |
| Employee Benefit Expenses | 515.30 | 454.90 | 425.70 | 410.10 | 380.00 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,465.60 | 1,741.70 | 930.20 | 307.60 | 518.70 |
| Interest | 19.60 | 14.50 | 8.60 | 13.30 | 11.30 |
| Gross Profit | 2,446.00 | 1,727.20 | 921.60 | 294.30 | 507.40 |
| Depreciation | 220.00 | 171.90 | 150.90 | 138.40 | 115.20 |
| Profit Before Tax | 2,226.00 | 1,555.30 | 770.70 | 155.90 | 392.20 |
| Current Tax | 407.50 | 284.80 | 133.10 | 32.50 | 93.30 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -31.90 | -36.10 | 0.50 | -15.70 | -10.60 |
| Reported Net Profit | 1,850.40 | 1,306.60 | 637.10 | 139.10 | 309.50 |
| Extraordinary Items | 72.22 | -2.12 | 14.71 | 33.80 | 24.39 |
| Adjusted Net Profit | 1,778.18 | 1,308.72 | 622.39 | 105.30 | 285.11 |
| Adjustment below Net Profit | 3.00 | -44.70 | -1.00 | 0.40 | 2.20 |
| Profit/Loss Balance carried down | 4,226.30 | 3,134.60 | 2,587.10 | 2,520.50 | 2,322.50 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 107.50 | 170.20 | 88.60 | 72.90 | 113.90 |
| P & L Balance carried down | 5,972.20 | 4,226.30 | 3,134.60 | 2,587.10 | 2,520.30 |
| Dividend | 0.00 | 170.20 | 100.40 | 82.10 | 113.90 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 300.00 | 475.00 | 275.00 | 225.00 | 262.50 |
| Dividend Per Share(Rs) | 6.00 | 9.50 | 5.50 | 4.50 | 5.25 |
| Earnings Per Share-Unit Curr | 103.37 | 72.99 | 34.91 | 7.62 | 16.96 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 409.72 | 312.42 | 257.64 | 229.69 | 224.17 |
| Book Value(Adj)-Unit Curr | 409.72 | 312.42 | 257.64 | 229.69 | 224.17 |